30.11.2017
- In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...
09.03.2017
- The UK’s Competition and Markets Authority (CMA) has accused Concordia and Actavis UK of breaking competition law by agreeing to delay competition and keeping the price of...
